0000950170-24-002211.txt : 20240104
0000950170-24-002211.hdr.sgml : 20240104
20240104191457
ACCESSION NUMBER: 0000950170-24-002211
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Swisher Daniel N JR
CENTRAL INDEX KEY: 0001323113
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 24513982
MAIL ADDRESS:
STREET 1: C/O SUNESIS PHARMACEUTICALS, INC.
STREET 2: 395 OYSTER POINT BLVD., SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
ownership.xml
4
X0508
4
2024-01-02
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001323113
Swisher Daniel N JR
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
true
false
false
false
true
Common Stock
2024-01-02
4
M
false
2200
5.86
A
2200
D
Common Stock
2024-01-02
4
S
false
2200
22.11
D
0
D
Stock option (right to buy)
5.86
2024-01-02
4
M
false
2200
0
D
2026-07-21
Common Stock
2200
13350
D
The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.
Fully exercisable.
The power of attorney under which this form was signed is on file with the Commission.
/s/ Joseph Douglas Lyon, as attorney-in-fact for Daniel N. Swisher, Jr.
2024-01-04